Risk
factors for endo Ca?? The biggest concern should be
endometrial cancer. She also has one risk
factors for endometrial cancer including obesity , , hypertension, but fortunately
diabetes, prior anovulation , late
menopause and nulliparity are not therte . The endometrial
sampling or aspiration can be
performed in the office by placing
a thin flexible catheter
through the cervix. It is the initial
test of choice to assess for endometrial cancer. This
patient is not taking unopposed
estrogen replacement therapy which would be another risk factor. If endometrial cancer was diagnosed the patient would need surgical staging. If the endometrial sampling is
negative for cancer another cause for post menopausal bleeding
such as atrophic endometrium is possible.
How
accurate is traditional D & C to detect Endo ca?? A blind sampling of the endometrium
such as with the endometrial biopsy
device, has 90% to 95% sensitivity for detecting cancer. If this
patient who has so many risk factors for endometrial cancer, were to have a negative endometrial sampling many practitioners would go to a direct visualization of the endometrial cavity
such as hysteroscopy . If the clinician
were to elect to observe this patient after the
endometrial biopsy any further
bleeding episodes would
necessitate further investigation.
ATROPHIC
ENDOMETIUM : The most common cause of
postmenopausal bleeding is
friable tissue of the endometrium or
vagina due to low estrogen
levels.
ENDOEMTRIAL STRIPE:
Transvaginal sonographic assessment
of the endometrial thickness a thickness greater than 5 mm
is abnormal in a postmenopausal
woman.
Clinical approach ?? Priciple:-
Postmenopausal bleeding always needs to be
investigated because it can indicate
malignant disorders and premalignant conditions, such as endometrial hyperplasia. Notably complex
hyperplasia with atypia is associated
with endometrial carcinoma in 30 %
to 50% of cases.
Approximately 20 % of postmenopausal women not on hormonal therapy but complaining of vaginal
bleeding will have an
endometrial carcinoma. The most common
etiology of postmenopausal bleeding
is atrophic endometritis or
vaginitis also vaginal
spotting can occur in a patient taking hormonal therapy . However
since endometrial malignancy can
coexist with atrophic changes or in women taking hormone replacement therapy
endometrial carcinomas must be ruled out in any patient with postmenopausal bleeding. Possible methods for
assessment of the endometrium
include endometrial
sampling hysteroscopy or vaginal
sonography.
They primarily include conditions of estrogen
exposure without progesterone. Although
endometrial cancer
typically affects older women a woman in her 30s with a history of chronic anovulation such as polycystic ovarian syndrome may be affected. When the
endometrial sampling is unrevealing the
patient with persistent
postmenopausal bleeding or with
numerous risk factors for endometrial cancer
should undergo further
evaluation such as by hysteroscopy.
Direct visualization of uterine
cavity can identify small lesions
that may be missed by the
office endometrial sampling device. Additionally
endometrial polyps can be
identified by hysteroscopy.
Endometrial
carcinoma is the most common female
genital tract malignancy . Although endometrial cancer is not the most common cause of post menopausal bleeding it is usually the one of most concern. Fortunately because endometrial
cancer is associated with an early symptom, postmenopausal bleeding , it is usually detected at an early stage.
Once diagnosed endometrial cancer
is staged surgically . Sometimes
endometrial cancer may occur in the
atypical patient such as a thin patient
these cancers tend to be more
aggressive.
DEFINITIONS
ENDOMETRIAL
SAMPLING: A thin catheter is introduced through
the cervix into the uterine cavity under
some suction to aspirate
endometrial cells.
ENDOMETRIAL
POLYPS : A growth of endometrial glands and stroma , which projects
into the uterine cavity usually
on a stalk ; it can cause postmenopausal
bleeding.
No comments:
Post a Comment